1. Home
  2. NNI vs CYTK Comparison

NNI vs CYTK Comparison

Compare NNI & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNI
  • CYTK
  • Stock Information
  • Founded
  • NNI 1978
  • CYTK 1997
  • Country
  • NNI United States
  • CYTK United States
  • Employees
  • NNI N/A
  • CYTK N/A
  • Industry
  • NNI Finance: Consumer Services
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • NNI Finance
  • CYTK Health Care
  • Exchange
  • NNI Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • NNI 4.7B
  • CYTK 4.6B
  • IPO Year
  • NNI 2003
  • CYTK 2004
  • Fundamental
  • Price
  • NNI $131.71
  • CYTK $57.51
  • Analyst Decision
  • NNI
  • CYTK Strong Buy
  • Analyst Count
  • NNI 0
  • CYTK 15
  • Target Price
  • NNI N/A
  • CYTK $76.73
  • AVG Volume (30 Days)
  • NNI 66.5K
  • CYTK 2.0M
  • Earning Date
  • NNI 11-06-2025
  • CYTK 11-05-2025
  • Dividend Yield
  • NNI 0.91%
  • CYTK N/A
  • EPS Growth
  • NNI 116.62
  • CYTK N/A
  • EPS
  • NNI 9.04
  • CYTK N/A
  • Revenue
  • NNI $1,559,342,000.00
  • CYTK $85,738,000.00
  • Revenue This Year
  • NNI $12.03
  • CYTK $363.61
  • Revenue Next Year
  • NNI $5.34
  • CYTK $64.08
  • P/E Ratio
  • NNI $14.58
  • CYTK N/A
  • Revenue Growth
  • NNI 21.39
  • CYTK 2635.74
  • 52 Week Low
  • NNI $98.15
  • CYTK $29.31
  • 52 Week High
  • NNI $136.17
  • CYTK $63.86
  • Technical
  • Relative Strength Index (RSI)
  • NNI 58.66
  • CYTK 54.85
  • Support Level
  • NNI $128.79
  • CYTK $57.51
  • Resistance Level
  • NNI $133.58
  • CYTK $60.00
  • Average True Range (ATR)
  • NNI 2.56
  • CYTK 2.63
  • MACD
  • NNI 0.24
  • CYTK -0.88
  • Stochastic Oscillator
  • NNI 74.51
  • CYTK 33.58

About NNI Nelnet Inc.

Nelnet Inc is a United States based company engaged in these four reportable segments; Loan Servicing and Systems focuses on student and consumer loan origination services and servicing, loan origination and servicing-related technology solutions, and outsourcing business services; Education Technology Services and Payments segment provides education services, payment technology, and community management solutions for K-12 schools, institutions, churches, and businesses; Asset Generation and Management segment includes the acquisition and management of student and other loan assets; and Nelnet Bank focuses on the private education and unsecured consumer loan markets. Maximum revenue for the company is generated from its Education Technology Services and Payments segment.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: